Clinical Performance and Safety of the Unicompartmental Univation® XF Pro Implant

NCT ID: NCT06657248

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-01-31

Study Completion Date

2031-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is designed as a prospective, observational, mid-term, multi-center follow-up study. It is planned to include 150 patients from 4 different study centres in Germany.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The product under investigation is used in routine clinical practice and according to the authorized Instructions for Use (IfU). The data that is obtained in routine clinical use will be documented in an electronical Case Report Form (eCRF). The study's main purpose is the collection of clinical data on the safety and performance of the redesigned univation® XF Pro implant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gonarthritis Degenerative Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

univation® XF Pro

Primary medial unicompartmental knee arthroplasty treated with implantation of unicompartmental knee prosthesis univation® XF Pro

univation® XF Pro

Intervention Type DEVICE

Primary medial unicompartmental knee arthroplasty

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

univation® XF Pro

Primary medial unicompartmental knee arthroplasty

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Unicompartmental knee arthroplasty

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for a primary medial unicompartmental knee endoprosthesis

Acc. to Instructions for Use:

* Both cruciate ligaments intact
* Lateral ligaments intact
* Leg axis amenable to passive correction
* Varus deformity under 15°
* Bending capability of at least 90°
* Extension deficit no greater than 5-10°
* Written informed consent of patient
* Kellgran \& Lawrence Score \> II (only straight or varus
* Patients with moderate radiological symptoms
* Patients without clinical symptoms

Exclusion Criteria

* Pregnancy
* Patient age \<18 and \> 75 years
* BMI ≥ 40
* High risk patients ASA \> III
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Raylytic GmbH

INDUSTRY

Sponsor Role collaborator

Aesculap AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rolf Haaker, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

St. Vincenz Hospital Brakel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oberlinklinik gGmbH

Potsdam, Brandenburg, Germany

Site Status

Lukas Krankenhaus

Bünde, North Rhine-Westphalia, Germany

Site Status

St. Vincenz Hospital Brakel

Brakel, , Germany

Site Status

LMU Großhadern

München, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Petra Wain

Role: CONTACT

+49746195

Stefan Maenz, Dr.

Role: CONTACT

+49746195

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Robert Krause, Dr.

Role: primary

Michael Menges, Dr.

Role: primary

Rolf Haaker, Prof. Dr.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AAG-O-H-22003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Persona Partial Knee Clinical Outcomes Study
NCT03034811 ACTIVE_NOT_RECRUITING NA
FH ORTHO SAS Knee Observatory
NCT06207968 NOT_YET_RECRUITING